LivPhcD
AssetAlso LivPhcDTM
Hepatoprotective dietary supplement for non-alcoholic fatty liver disease.
- Stage
- Human trials
- Modality
- Supplement
- Target
- Not known
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1NAFLD
Human trials, Completed, NCT05930093, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Owner and partners1
- Trials1
Every asset’s record: target, stage, trials and the evidence behind it.